相关实验视频
Updated: Feb 19, 2026
11:07
Focal Laser Ablation of Prostate Cancer: An Office Procedure
Published on: March 30, 2021
8.5K
[前列腺动脉栓塞 (PAE) 治疗良性前列腺增生 (BPH) 的现状]
Christian R Habermann1, Nando Mertineit1
1Marienkrankenhaus, Institute of diagnostic and interventional Radiology.
Aktuelle Urologie
|February 17, 2026
概括
前列腺动脉栓塞 (PAE) 为良性前列腺增生 (BPH) 提供了一种微创的选择,显示症状改善和前列腺收缩. 虽然提供比手术更低的风险和更好的射精保存,但中期的再干预率需要患者讨论.
科学领域:
- 干预性放射学 干预性放射学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 医疗器械技术 医疗器械技术
背景情况:
- 良性前列腺增生 (BPH) 是一种常见的疾病,导致下泌尿道症状 (LUTS).
- 前列腺动脉栓塞 (PAE) 已成为BPH的最小侵入性治疗方法.
- 本综述综合了关于PAE用于BPH管理的当前知识.
研究的目的:
- 为BPH提供PAE的全面概述.
- 涵盖技术方面,患者选择,疗效,安全和经济因素.
- 讨论PAE在临床指南中的定位.
主要方法:
- 对BPH的PAE前性研究和元分析的审查.
- 分析技术原则,包括栓塞剂和导航.
- 评估临床结果,安全概况和健康经济数据.
主要成果:
- PAE显著降低了LUTS,改善了生活质量,并降低了前列腺体积.
- 与TUR-P和HoLEP相比,PAE的程序风险较低,并且更好地保留了前分级射精,并改善了更温和的流速.
- 在PAE中,中期重新干预率更高,需要明确的患者咨询.
结论:
- PAE是BPH的一个有价值的最小侵入性选择,特别是对于大前列腺或并发症/抗凝血患者.
- 经验丰富的中心使用先进的导航和标准化的协议实现更好的结果.
- 需要进一步的长期数据和标准化技术来巩固PAE在BPH指南中的作用.
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
529
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
529
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
492
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
492